Related Experiment Video
Updated: Jan 19, 2026

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
Published on: January 21, 2019
Thematic Issue: Immuno-Oncology and Immunotherapy
1Sechenov First Moscow State Medical University, Institute of Molecular Medicine, Moscow, 119991, Russia. zamyat@belozersky.msu.ru.
Cancer immunotherapy is a promising field, but challenges remain. This issue explores current advancements and diverse perspectives from experts in cancer treatment.
Area of Science:
- Oncology
- Immunology
Background:
- Cancer immunotherapy represents a significant advancement in oncology.
- Despite progress, challenges in immuno-oncology persist.
Purpose of the Study:
- To highlight topical aspects of cancer immunotherapy.
- To present diverse viewpoints from scientists, physicians, and drug developers.
Main Methods:
- Thematic issue compilation.
- Review of current research and expert opinions.
Main Results:
- Identification of unresolved problems in cancer immunotherapy.
- Exploration of various perspectives on current advancements.
Conclusions:
- Cancer immunotherapy continues to be a rapidly evolving and critical area of research.
- Multidisciplinary collaboration is essential for overcoming existing challenges in the field.
More Related Videos
Related Concept Videos
10:49Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
08:17A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
Thematic Layering in GIS
06:51Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
Ethical Issues
Ethical Concerns in Healthcare:
Tumor Immunotherapy

